Navigation Links
Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology
Date:7/24/2014

CAMPBELL, Calif., July 24, 2014 /PRNewswire/ -- Lazarus Effect, a medical device company focused on the development of novel interventional devices to facilitate removal of blood clots, announced today that the United States Patent and Trademark Office has issued a new patent (U.S. Patent Number 8,795,305) covering core technology behind the company's Lazarus CoverTM and ReCoverTM devices.

The Lazarus ReCover is a single-component stent-retriever (stentriever) with an integrated, novel, cover-based protection mechanism integrated onto the device. It is designed to cover and protect thrombus and to prevent loss of emboli during thrombectomy (clot removal) procedures. The Lazarus Cover is a unique, nitinol mesh cover that can be used with a variety of available retriever devices (including stentrievers) to protect the captured contents against loss during removal from the blood vessel.   

"This latest patent provides strong protection for Lazarus Effect technology that covers and protects captured content during retrieval procedures," said Martin Dieck, chairman and CEO, Lazarus Effect. "This patent will be a cornerstone in a series of Lazarus Effect patents relating to protected - and therefore improved - retrieval procedures."

The issued patent adds to the comprehensive patent portfolio Lazarus Effect has been building. The company currently has five issued US patents and numerous pending US and worldwide patent applications, including a patent issued in May 2014 covering additional technology related to the removal of clots in the brain. The Lazarus ReCover device has CE Mark for use in Europe. The Lazarus Cover device is pending CE Mark. Neither device is approved for sale in the United States.

About Lazarus Effect

Lazarus Effect is developi
'/>"/>

SOURCE Lazarus Effect
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idecs Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted
2. New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice
3. Clinical Trial Demonstrates That EarlySense May Be An Effective Indicator for Respiratory Pattern Recognition
4. New England Journal of Medicine Study Finds Upper-Airway Electronic Stimulation Effective for Obstructive Sleep Apnea
5. ObamaCare: Health Care Reform and its Effect on Sleep Apnea
6. Improving the Quality and Effectiveness of Marketing Services Groups in an Environment Characterized by Globalization and Shrinking Resources
7. New England Journal of Medicine releases study showing GSKs FluLaval Quadrivalent vaccine effective in preventing seasonal flu in children
8. Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65
9. Highland Instruments, Inc., Announces Presentation of "Effects of Electrosonic Stimulation on the Perception of Chronic Pain Due to Osteoarthritis of the Knee."
10. Frost & Sullivan Applauds Definiens Strong Technology Portfolio for the Effective Data Analysis of Histology Images
11. Ensuring Critical Leadership Messages are Effectively Communicated Across an Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 2014 Quantum Materials Corp (OTCQB:QTMM) today ... photoactive quantum dots for use in next-generation ... advantages for solar power generation, the high cost ... dots with which to develop thin film solar ... utilization and acceptance. The company is also seeking ...
(Date:10/1/2014)... Oct. 1, 2014 Ardelyx, Inc. ... biopharmaceutical company focused on cardio-renal, gastrointestinal and ... its 371 patient Phase 2b clinical trial ... bowel syndrome (IBS-C).  Results from this study ... in IBS-C symptoms for tenapanor-treated patients compared ...
(Date:10/1/2014)... , October 1, 2014 ... Next Generation Sequencing (NGS) data analysis, today launches a ... cystic fibrosis analysis in a single NGS experiment. The ... all types of variants in a single NGS experiment ... it has not been possible to simultaneously analyse all ...
Breaking Medicine Technology:Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2
... ST. LOUIS, April 21, 2011 / PRNewswire/ ... FDA approved liquid potassium iodide product indicated for thyroid ... has implemented the changes necessary to ramp up production ... ThyroShield is an over-the-counter iodide solution which, ...
... Ind., April 21, 2011 Hill-Rom Holdings, Inc., (NYSE: ... a management presentation at Deutsche Bank,s 36th Annual Health ... 2:10 p.m. ET. You are invited to ... at http://ir.hill-rom.com/events.cfm or access it directly at ...
Cached Medicine Technology:Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield® 2
(Date:10/1/2014)... Lifeinsurance-policy.com has released a new blog post explaining how ... , Smoking will always have a negative impact on ... method to find affordable coverage. Insurance brokerage websites specialize ... , Whole life insurance premiums will be fixed throughout ... is permanent, the initial rates are very important. ...
(Date:10/1/2014)... FARMINGTON, Conn. (PRWEB) October 01, 2014 ... its company, including a redefined mission and visual ... the power of partnering with them to create ... more agile brand that focuses on empowering customers ... benefits communications. , The crown jewel of the ...
(Date:10/1/2014)... Maine (PRWEB) October 01, 2014 Between ... disorders in the U.S., according to figures from the ... Related Diseases Association (AARDA), and many of them have ... chance of having undiagnosed celiac disease. Gluten Free ... raise awareness of undiagnosed celiac disease by publishing a ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Anti Aging ... and skin rejuvenating destination of choice, is announcing a ... October through to December. , “We’re doing this because ... possible to our top skin clinic in Toronto,” says ... do so much at Anti Aging Clinic, including laser ...
(Date:10/1/2014)... Nordic Naturals is kicking off a ... The campaign—“Buy One Bottle. Help Two Heroes.”—will raise ... nonprofit organization that helps rebuild the lives of ... would otherwise face euthanasia. From October through December ... donations of Nordic Naturals omega-3s to veterans and ...
Breaking Medicine News(10 mins):Health News:Affordable Whole Life Insurance Premiums for Smokers! 2Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2Health News:Nordic Naturals® Inspires Support for Paws for Veterans -- ‘Buy One Bottle. Help Two Heroes.’ Initiative Kicks Off October 1 2
... (HealthDay News) -- Telling yourself that an angry person is just ... help take the sting out of their ire, a new study ... angry person is an approach commonly suggested in cognitive behavioral therapy. ... just lost his dog or received bad news and is taking ...
... Emergency Department fellow Alyssa Turner, M.D., has been ... presentation at the American Academy of Pediatrics annual ... Blocks in the Pediatric Emergency Department," was deemed ... a physician-in-training. Turner and co-authors Keith ...
... , FRIDAY, Nov. 18 (HealthDay News) -- Those in the ... U.S. government health experts now encourage Americans to ... new system assigns no points to nearly all fruits and ... what,s the big deal? Why is it so important to ...
... , FRIDAY, Nov. 18 (HealthDay News) -- Women who ... therapy have a 33 percent higher risk of developing breast ... study says. It also found that new-onset breast tenderness ... taking estrogen alone. The findings, based on an analysis ...
... , FRIDAY, Nov. 18 (HealthDay News) -- Skilled ... they see them, a new study indicates. Instead, once ... in their brains to recognize it every time they see ... these findings could provide new insight into certain reading disorders. ...
... Montreal, November 17, 2011 -- Colleagues who work ... seasonal as the flu. Yet are sick employees workplace troopers ... new study from Concordia University, published in the Journal ... attending work when ill, isn,t always a productive option. ...
Cached Medicine News:Health News:Think 'It's Not Me, It's You,' When Dealing With Angry Person 2Health News:For Nutritional Punch, You Can't Beat Plant-Based Foods 2Health News:For Nutritional Punch, You Can't Beat Plant-Based Foods 3Health News:For Nutritional Punch, You Can't Beat Plant-Based Foods 4Health News:Tender Breasts From Combo HRT Linked to Higher Cancer Risk 2Health News:Words Recognized by Looks, Not Sounds 2Health News:Presenteeism: A new word for working when sick 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: